澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CYNATA THERAPEUTICS LTD

0.011

0.000

成交量：14.91萬

成交額：1,640

市值：267.80萬

市盈率：-0.30

高：0.011

開：0.011

低：0.011

收：0.011

52周最高：0.435

52周最低：0.011

股本：2.43億

流通股本：1.76億

量比：0.29

換手率：0.08%

股息：- -

股息率：- -

每股收益(TTM):-0.037

每股收益(LYR):-0.046

淨資產收益率：-112.99%

總資產收益率：-62.05%

市淨率：0.79

市盈率(LYR):-0.24

資料載入中...

總覽公司新聞資訊公告

概念

新冠治療股+2.33%

醫藥生物股+2.85%

資金流向

資金流入：

資金流出：

新聞資訊

Cynata Therapeutics宣佈所有職位冗餘，包括CEO和董事總經理，自2026年7月6日起生效

Cynata Therapeutics Ltd獲150萬澳元機構配售承諾每股定價0.25澳元

Cynata Therapeutics Ltd 申請停牌待公布配股融資計劃

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/CYP.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CYP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CYP.AU\",,,,,undefined,":{"symbol":"CYP.AU","market":"AU","secType":"STK","nameCN":"CYNATA THERAPEUTICS LTD","latestPrice":0.011,"timestamp":1787638320000,"preClose":0.011,"halted":0,"volume":149110,"delay":0,"changeRate":0,"nameEN":"CYNATA THERAPEUTICS LTD","floatShares":175624818,"shares":243454369,"eps":-0.036606,"marketStatus":"未開盤","change":0,"latestTime":"08-25 16:12:00 AEST","open":0.011,"high":0.011,"low":0.011,"amount":1640,"amplitude":0,"askPrice":0.012,"askSize":542284,"bidPrice":0.011,"bidSize":1068584,"shortable":3,"etf":0,"ttmEps":-0.036606,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.011,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.285937826640245,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CYP.AU","preClose":0.011,"auctionPrice":0.012,"auctionVolume":216,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292007381}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CYP.AU\",,,,,undefined,":{"symbol":"CYP.AU","floatShares":175624818,"roa":"-62.05%","roe":"-112.99%","lyrEps":-0.045818,"volumeRatio":0.285937826640245,"shares":243454369,"dividePrice":0,"high":0.011,"amplitude":0,"preClose":0.011,"low":0.011,"week52Low":0.011,"pbRate":"0.79","psRate":"1.59","week52High":0.435,"institutionHeld":0,"latestPrice":0.011,"committee":0.326718,"eps":-0.036606,"divideRate":0,"volume":149110,"delay":0,"ttmEps":-0.036606,"open":0.011,"prevYearClose":0.345,"prevWeekClose":0.012,"prevMonthClose":0.012,"prevQuarterClose":0.014,"fiveDayClose":0.011,"twentyDayClose":0.012,"sixtyDayClose":0.28,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYP.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-12-15","symbol":"CYP.AU","defaultRemindTime":1607986800000,"type":"split","dateTimestamp":1607950800000,"forFactor":2147483647,"toFactor":2147483647,"ratio":0.997023}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CYP.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127988801","title":"Cynata Therapeutics宣佈所有職位冗餘，包括CEO和董事總經理，自2026年7月6日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1127988801","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127988801?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 06:37","pubTimestamp":1783291032,"startTime":"0","endTime":"0","summary":"Cynata Therapeutics Ltd已决定裁撤所有员工职位，这一重大调整涵盖了首席执行官及董事总经理的职务。该决定将于2026年7月6日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYP.AU","BK7508","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114494982","title":"Cynata Therapeutics Ltd獲150萬澳元機構配售承諾 每股定價0.25澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114494982","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114494982?lang=zh_tw&edition=fundamental","pubTime":"2026-05-04 07:06","pubTimestamp":1777849576,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术公司Cynata Therapeutics Ltd宣布成功获得机构投资者认购承诺，将以每股0.25澳元的价格完成总额150万澳元的配售融资。此次定向增发将为企业后续临床研究及运营提供资金支持。\n该定价较公司近期交易均价呈现一定溢价，反映出机构投资者对Cynata核心细胞治疗技术平台的信心。公司独有的Cymerus™技术平台能够实现干细胞疗法的规模化生产，目前正推进针对骨关节炎、移植物抗宿主病等适应症的临床阶段研究。\n此次融资所得将主要用于加速主要候选产品的临床试验进程，同时加强企业知识产权布局。公司首席执行官表示，机构投资者的积极参与印证了市场对其创新疗法的商业前景认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYP.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133718843","title":"Cynata Therapeutics Ltd 申請停牌 待公布配股融資計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1133718843","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133718843?lang=zh_tw&edition=fundamental","pubTime":"2026-04-30 07:04","pubTimestamp":1777503851,"startTime":"0","endTime":"0","summary":"Cynata Therapeutics Ltd 已向交易所申请暂停股票交易，等待公司就拟议通过配股方式进行融资的事项发布正式公告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","CYP.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CYP.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治療股","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.023275},{"market":"AU","name":"醫藥生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.0285}]}}